Blood Neurofilament Light Chain Levels and Association with Brain Volume Change in Patients with Primary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis Before and During Ocrelizumab Treatment

被引:0
|
作者
Jia, Xiaoming [1 ]
Herman, Ann [1 ]
Harp, Christopher [1 ]
Cross, Anne [2 ]
Fiore, Damian [1 ]
Hauser, Stephen [3 ]
Kappos, Ludwig [4 ]
Koendgen, Harold [5 ]
Kuhle, Jens [4 ]
Leppert, David [4 ]
Manfrini, Marianna [5 ]
Model, Fabian [5 ]
Oksenberg, Jorge [3 ]
Sauter, Annette [5 ]
Thanei, Gian-Andrea [5 ]
Bar-Or, Amit [6 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Washington Univ, Sch Med, St Louis, MO 14263 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Hosp Basel, Basel, Switzerland
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
3926
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Kappos, Ludwig
    Hauser, Stephen
    Montalban, Xavier
    Buffels, Regine
    Chin, Peter
    Li, Carrie
    Mortensen, Deborah
    Napieralski, Julie
    Van Beek, Johan
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
  • [22] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [23] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY
    Hauser, Stephen L.
    Belachew, Shibeshih
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1694 - 1694
  • [24] Reduction of intrathecal immunoglobulin levels with ocrelizumab treatment in relapsing and primary progressive multiple sclerosis
    Weber, Martin
    Gelfand, Jeffrey
    Bar-Or, Amit
    Cameron, Briana
    Ramesh, Akshaya
    Anania, Veronica
    von Budingen, H. -Christian
    Herman, Ann
    Spiciarich, David
    Grondey, Katja
    Schuetz, Konstantin
    Winger, Ryan
    Jia, Xiaoming
    Harp, Christopher
    Cross, Anne
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 570 - 571
  • [25] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Hartung, H. -P.
    Arnold, D. L.
    Bar-Or, A.
    Comi, G.
    de Seze, J.
    Giovannoni, G.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 658 - 659
  • [26] Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    Rammohan, Kottil W.
    Hartung, Hans-Peter
    Arnold, Douglas L.
    Bar-Or, Amit
    Comi, Giancarlo
    de Seze, Jerome
    Giovannoni, Gavin
    Hauser, Stephen L.
    Hemmer, Bernhard
    Kappos, Ludwig
    Lublin, Fred
    Montalban, Xavier
    Selmaj, Krzysztof
    Traboulsee, Anthony
    Chin, Peter
    Li, Carrie
    Mairon, Nicole
    Napieralski, Julie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 31 - 32
  • [27] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis
    Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Susan
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    NEUROLOGY, 2023, 100 (17)
  • [28] Siponimod Reduces Neurofilament Light Chain Blood Levels in Secondary Progressive Multiple Sclerosis Patients
    Kuhle, Jens
    Kropshofer, Harald
    Barro, Christian
    Meinert, Rolf
    Haring, Dieter A.
    Leppert, David
    Tomic, Davorka
    Dahlke, Frank
    Kappos, Ludwig
    NEUROLOGY, 2018, 90
  • [29] Serum neurofilament light chain levels correlate strongly with cognitive status in patients with relapsing and progressive multiple sclerosis
    Edwards, K.
    Kamath, A.
    O'Connor, J.
    Kamath, V.
    Whidden, C.
    Button, A.
    Button, J.
    Bruso, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP6 - NP8
  • [30] Infusion-related reactions with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis
    De Seze, J.
    Arnold, D. L.
    Bar-Or, A.
    Giovannoni, G.
    Hartung, H. -P.
    Hauser, S. L.
    Hemmer, B.
    Kappos, L.
    Lublin, F.
    Montalban, X.
    Rammohan, K. W.
    Selmaj, K.
    Traboulsee, A.
    Wolinsky, J.
    Chin, P.
    Li, C.
    Mairon, N.
    Napieralski, J.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 351 - 352